Applied Genetic Technologies (AGTC) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. BROS
3. ARM
4. FIS
5. EXPE
6. QCOM
7. DDOG
8. PAYC
9. CHYM
10. CPAY

Go back to Applied Genetic Technologies (AGTC) Tops Q3 EPS by 6c

AGTC Announces Financial Results for the Quarter Ended March 31, 2016

May 9, 2016 4:03 PM EDT

GAINESVILLE, Fla., and CAMBRIDGE, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, with a primary focus on ophthalmology, today announced financial results for the quarter ended March 31, 2016. The company also announced that it plans to expand its AAV technology platform to address targets that could help treat patients with inherited hearing disorders.

Weve continued to make progress over the past several months to advance our gene... More